Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)
Proposal to Create a Flagship Neurology and Palliative Care Service for South London
Sponsor: King's College London
A PHASE1/PHASE2 clinical study on Multiple Sclerosis, this trial is completed. The trial is conducted by King's College London and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
First recorded
Mar 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- King's College London
- National Multiple Sclerosis Society
For direct contact, visit the study record on ClinicalTrials.gov .